BLCO peer analysis
Bausch + Lomb (BLCO) against its competitors: price, today's move, 1-year return and market value side by side.
BLCO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARWR Arrowhead | $58.16 | 1.22% | 42.24% | $8.12B |
| CRSP CRISPR Therapeutics | $49.35 | 1.63% | -12.79% | $4.71B |
| GKOS Glaukos | $224.41 | 2.01% | 165.60% | $13.02B |
| MMSI Merit Medical | $87.23 | -2.67% | 1.48% | $5.37B |
| OSCR Oscar Health | $30.58 | -7.84% | 83.38% | $10.24B |
| PCVX Vaxcyte | $64.05 | 3.44% | 54.65% | $9.80B |
| PTCT PTC Therapeutics | $65.39 | -0.43% | -7.55% | $5.49B |
| TFX Teleflex | $150.87 | -0.84% | 19.90% | $6.45B |
| TGTX TG Therapeutics | $59.75 | 3.05% | 69.45% | $8.87B |
| BLCO Bausch + Lomb | $19.99 | 0.35% | 25.11% | – |
- BLCO's peers: ARWR (Arrowhead), CRSP (CRISPR Therapeutics), GKOS (Glaukos), MMSI (Merit Medical), OSCR (Oscar Health), PCVX (Vaxcyte), PTCT (PTC Therapeutics), TFX (Teleflex).
Updated 2026-11-07 11:55 UTC